Back

Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Lipids as risk factors for cardiovascular disease Diabetes and the Heart ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Kailun Yan

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

8 More presentations in this session

Presentation thumbnail
Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study
Associate Professor K. Cho (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population
Doctor V. Zorzanelli Rocha (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Association between lipoprotein particle concentration and size and progression of coronary plaque: the MACS Longitudinal Coronary CT angiography study
Doctor R. Quispe (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank
Doctor B. Tucker (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)
Doctor H. Carlton (Chichester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as risk factors for cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Sex-specific associations between remnant cholesterol and cardiovascular risk in patients undergoing percutaneous coronary intervention: a 5-year large-sample study from the real world
thumbnail
Congress Presentation
Residual cholesterol:a non-predictive marker for major adverse cardiovascular events in patients with intermediate coronary lesions: a large-scale multicenter study
thumbnail
Congress Presentation
Remnant cholesterol-inflammatory index predicts antiplatelet reactivity and 5-year ischemic risk: a cohort study of 6,555 post-PCI patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources